REFERENCES
- S. Azarmi, W. H. Roa, and R. Lobenberg. (2008). Targeted delivery of nanoparticles for the treatment of lung diseases. Adv. Drug Deliv. Rev. 60 (8):863–875.
- S. Azarmi, X. Tao, H. Chen, Z. Wang, W. H. Finlay, R. Löbenberg, and W. H. Roa. (2006). Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Int. J. Pharm. 319:155–161.
- M. Brzoska, K. Langer, C. Coester, S. Loitsch, T. O. F. Wagner, and C. V. Mallinckrodt. (2004). Incorporation of biodegradable nanoparticles into human airway epithelium cells—in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases. Biochem. Biophys. Res. Commun. 318 (2):562–570.
- L. A. Dailey, N. Jekel, L. Fink, T. Gessler, T. Schmehl, M. Wittmar, T. Kissel, and W. Seeger. (2006). Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Toxicol. Appl. Pharmacol. 215:100–108.
- L. Ely, W. Roa, W. H. Finlay, and R. Löbenberg. (2007). Effervescent dry powder for respiratory drug delivery. Eur. J. Pharm. Biopharm. 65 (3):346–353.
- W. H. Finlay. The mechanics of inhaled pharmaceutical aerosols: An introduction. Academic Press, San Diego, CA, (2001).
- N. R. Labiris, and M. B. Dolovich. (2003). Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br. J. Clin. Pharmacol. 56:588–599.
- G. Oberdorster, E. Oberdorster, and J. Oberdorster. (2005). Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113:823–839.
- J. O. H. Sham, Y. Zhang, W. H. Finlay, W. H. Roa, and R. Loebenberg. (2004). Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. Int. J. Pharm. 269 (2):457–467.
- D. Stuart, R. Löbenberg, T. Ku, S. Azarmi, L. Ely, W. Roa, and E. J. Prenner. (2006). Biophysical investigation of nanoparticle interactions with lung surfactant model systems. J. Biomed. Nanotech. 2 (3–4):245–252.
- N. Tsapis, D. Bennett, B. Jackson, D. A. Weitz, and D. A. Edwards. (2002). Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc. Nat. Acad. Sci. USA 99:12001–12005.
- Z. Wang, B. Grgic, and W. H. Finlay. (2006). A dry powder inhaler with reduced mouth-throat deposition. J. Aerosol. Med. 19:168–174.